pharmaphorum
JULY 28, 2022
The finding came from an analysis of sequencing data from more than 360,000 individuals in the UK Biobank , which contains genetic and health information from half a million UK participants. The post Alnylam finds belly fat gene and drug target in UK Biobank study appeared first on. Image by Bruno /Germany from Pixabay .
The Pharma Data
APRIL 11, 2023
Bayer will present the first clinical Phase 1 results on aryl hydrocarbon receptor (AhR) inhibitor BAY 2416964, the company’s most advanced Immuno-Oncology program.
The Pharma Data
JANUARY 21, 2021
Four years ago, the University of Malta established a national ALS Registry and Biobank to identify ALS patients and collect data on their residence, occupation, lifestyle and environmental exposures. Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that destroys the nerves linked to the muscles.
Expert insights. Personalized for you.
52 
Let's personalize your content